A Phase II Study of CCX282-B in Patients With Celiac Disease

NCT00540657 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Celiac Disease

Interventions

DRUG: CCX282-B
DRUG: Placebo

Sponsor

Amgen